×
Bayer Revenue 2010-2024 | BAYRY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Bayer revenue for the twelve months ending September 30, 2024 was
$50.613B
, a
0.31% decline
year-over-year.
Bayer annual revenue for 2023 was
$51.558B
, a
3.56% decline
from 2022.
Bayer annual revenue for 2022 was
$53.459B
, a
2.5% increase
from 2021.
Bayer annual revenue for 2021 was
$52.152B
, a
10.28% increase
from 2020.
View More
Bayer Revenue 2010-2024 | BAYRY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Bayer annual revenue for 2023 was
$51.558B
, a
3.56% decline
from 2022.
Bayer annual revenue for 2022 was
$53.459B
, a
2.5% increase
from 2021.
Bayer annual revenue for 2021 was
$52.152B
, a
10.28% increase
from 2020.
Related Stocks
Company Name
Market
Cap
Eli Lilly (LLY)
$759.4B
Novo Nordisk (NVO)
$387.1B
Johnson & Johnson (JNJ)
$342B
AbbVie (ABBV)
$309.5B
Merck (MRK)
$251.1B
AstraZeneca (AZN)
$207.8B
Novartis AG (NVS)
$202.5B
Pfizer (PFE)
$151.4B
Sanofi (SNY)
$123.7B
Innoviva (INVA)
$1.1B